Skip to main content

Advertisement

Fig. 5 | BMC Cancer

Fig. 5

From: The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy

Fig. 5

The imaging of a practice case: 70’s-year-old patient with lung and pancreas (head and tail) metastases treated by sorafenib (#1). The SUVmax of lung metastasis had suppressed during treatment, but the SUVmax of pancreas head metastasis increased before tumor was judged as PD. Fusion images were upper lanes. The number means SUVmax of each lesion. CT images were lower lanes. “Pre” refers to pretreatment evaluation; “M” refer to number of month after TKI treatment started

Back to article page